CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments
Ye Seul Yang, Seo Young Lee, Jung-Sun Kim, Kyung Mook Choi, Kang Wook Lee, Sang-Chol Lee, Jung Rae Cho, Seung-Jin Oh, Ji-Hyun Kim, Sung Hee Choi
Endocrinol Metab. 2020;35(2):367-376.   Published online June 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.2.367

Excel Download

Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments
Endocrinology and Metabolism. 2020;35(2):367-376   Crossref logo
Link1 Link2 Link3

Lipid target achievement among patients according to ESC/EAS and ACC/AHA guidelines in a lipid clinic
Atherosclerosis. 2014;235(2):e289   Crossref logo
Link1 Link2

News from the literature: Focus on joint ESC/EAS dyslipidemia guidelines
Atherosclerosis. 2012;220(1):42-44   Crossref logo
Link1 Link2

Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registry
International Journal of Cardiology. 2020;316:229-235   Crossref logo
Link1 Link2

2015 Korean Guidelines for Management of Dyslipidemia
Journal of Lipid and Atherosclerosis. 2015;4(1):61   Crossref logo
Link1 Link2 Link3

2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
Revista Española de Cardiología (English Edition). 2020;73(5):403   Crossref logo
Link1 Link2

Corrigendum to: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
European Heart Journal. 2019;41(44):4255-4255   Crossref logo
Link1 Link2

What is the potential cardiovascular risk reduction associated with achieving LDL-C levels recommended in the ESC/EAS guidelines for very high-risk patients? Data from 18 European countries
European Heart Journal. 2020;41(Supplement_2):   Crossref logo
Link1 Link2

Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines
Journal of Pharmaceutical Health Services Research. 2020;11(4):423-427   Crossref logo
Link1 Link2 Link3 Link4 Link5

Control of cardiovascular risk factors according to score system in hypertensive patients: ESC/EAS 2016 and 2019 dyslipidemia guidelines comparison
Atherosclerosis. 2020;315:e178   Crossref logo
Link1 Link2